Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;105:7-8
doi: 10.1161/CIRCRESAHA.109.201236
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pitt, G. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitt, G. S.
Related Collections
Right arrow Congestive
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Hypertrophy
Right arrow Ion channels/membrane transport
Right arrowRelated Article
(Circulation Research. 2009;105:7.)
© 2009 American Heart Association, Inc.


Editorials

Calcineurin Finds a New Partner in the L-Type Ca2+ Channel

Geoffrey S. Pitt

From the Ion Channel Research Unit, Department of Medicine, Duke University Medical Center, Durham, NC.

Correspondence to Geoffrey S. Pitt, Department of Medicine, Duke University Medical Center, Box 103030 Medical Center, Durham, NC 27710. E-mail geoffrey.pitt@duke.edu



See related articles, pages 51–60


Key Words: calcineurin • L-type Ca2+ channel • hypertrophy • phosphatase


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Calcineurin is a Ca2+/calmodulin-sensitive phosphatase that sits near the top of signaling pathways leading to pathological cardiac hypertrophy.1 Pathological stressors activate calcineurin, for which nuclear factor of activated T cells (NFAT) is a principal substrate. Dephosphorylation unmasks a nuclear localization signal on NFAT, which then translocates to the nucleus and, there, serves as part of a transcription factor complex able to initiate gene expression cascades that induce cardiac hypertrophy and subsequent heart failure. Determining how calcineurin is specifically activated in response to hypertrophic stressors by the same Ca2+ signal used for excitation–contraction coupling has been a major challenge. Triggered by Ca2+ influx through CaV1.2 voltage-gated Ca2+ channels at the sarcolemmal membrane, intracellular calcium briefly increases 10-fold with each heart beat to generate myocyte contraction. Almost as quickly, intracellular calcium falls to its baseline level, allowing myocyte relaxation and preparation for the next beat.

There are 2 leading proposals for how Ca2+ could activate the calcineurin/NFAT pathway or function as a versatile regulator of multiple other signaling cascades in the face of the large Ca2+ oscillations driving each cycle of contraction and relaxation. One is that modulation of the amplitude and/or frequency of the oscillatory contractile Ca2+ signal triggers particular Ca2+ sensors that then activate particular downstream signaling pathways, such as calcineurin activation.2 The alternative suggests that local Ca2+ signaling microdomains, secluded from the contractile oscillations, feed into specific signaling cascades, such as calcineurin activation.3,4 In this issue of Circulation Research, Tandan et al5 propose that calcineurin binds . . . [Full Text of this Article]


Related Article:

Physical and Functional Interaction Between Calcineurin and the Cardiac L-Type Ca2+ Channel
Samvit Tandan, Yanggan Wang, Thomas T. Wang, Nan Jiang, Duane D. Hall, Johannes W. Hell, Xiang Luo, Beverly A. Rothermel, and Joseph A. Hill
Circ. Res. 2009 105: 51-60. [Abstract] [Full Text] [PDF]